Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

61.42
+1.682.81%
Volume:1.04M
Turnover:63.11M
Market Cap:10.21B
PE:-17.65
High:61.42
Open:60.60
Low:59.70
Close:59.74
52wk High:86.74
52wk Low:41.71
Shares:166.18M
Float Shares:161.92M
Volume Ratio:0.52
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4800
EPS(LYR):-2.3812
ROE:-105.50%
ROA:-12.42%
PB:23.21
PE(LYR):-25.79

Loading ...

J.P. Morgan Sticks to Their Buy Rating for Ionis Pharmaceuticals (IONS)

TIPRANKS
·
May 20

Ionis Pharmaceuticals Initiated at Buy by Citigroup

Dow Jones
·
May 19

Ionis Pharmaceuticals initiated with a Buy, named a top pick at Citi

TIPRANKS
·
May 19

Assessing Ionis Pharmaceuticals (IONS) Valuation As Shares Cool After A Multi Year Run

Simply Wall St.
·
May 16

Ionis CEO Brett P. Monia disposes of USD 361,478 common shares

Reuters
·
May 16

Ionis Pharmaceuticals participates in a conference call with Cantor

TIPRANKS
·
May 15

BRIEF-Ionis Partner Biogen Announces Topline Results From Phase 2 Celia Study Of Diranersen

Reuters
·
May 14

Ionis Partner Biogen Announces Topline Results From Phase 2 Celia Study of Diranersen (Biib080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients With Early Alzheimer’s Disease

THOMSON REUTERS
·
May 14

Ionis director Joseph Loscalzo disposes of common shares worth $5.8 million

Reuters
·
May 07

Ionis director Joseph Klein III disposes of common shares worth $742,586.86

Reuters
·
May 06

Ionis Pharmaceuticals announces virtual annual shareholder meeting

Reuters
·
May 04

A Look At Ionis Pharmaceuticals (IONS) Valuation After FDA Priority Review Wins And Upgraded Revenue Guidance

Simply Wall St.
·
May 04

Ionis to present at Bank of America health care conference fireside chat

Reuters
·
May 01

Ionis EVP, Chief Business Officer Joseph Baroldi disposes of $116,755 common shares

Reuters
·
May 01

Ionis Pharmaceuticals price target raised to $100 from $95 at RBC Capital

TIPRANKS
·
Apr 30

RBC Lifts Price Target on Ionis Pharmaceuticals to $100 From $95, Keeps Outperform Rating

MT Newswires Live
·
Apr 30

Ionis Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 30

Ionis Pharmaceuticals price target raised to $125 from $120 at H.C. Wainwright

TIPRANKS
·
Apr 30

Ionis Pharmaceuticals Inc : H.c. Wainwright Raises Target Price to $125 From $120

THOMSON REUTERS
·
Apr 30

Ionis Pharmaceuticals’ Earnings Call Flags Growth and Risks

TIPRANKS
·
Apr 30